All Stories

  1. A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease
  2. Author Correction: In situ visualization of endothelial cell-derived extracellular vesicle formation in steady state and malignant conditions
  3. In situ visualization of endothelial cell-derived extracellular vesicle formation in steady state and malignant conditions
  4. Mapping where and when necroptotic cell death occurs in disease
  5. MLKL deficiency protects against low-grade, sterile inflammation in aged mice
  6. The web of death: the expanding complexity of necroptotic signaling
  7. Development of a carotid artery thrombolysis stroke model in mice
  8. A common humanMLKLpolymorphism confers resistance to negative regulation by phosphorylation
  9. Endothelial Caspase-8 prevents fatal necroptotic hemorrhage caused by commensal bacteria
  10. Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell death
  11. Human RIPK3 C-lobe phosphorylation is essential for necroptotic signaling
  12. Tankyrase-mediated ADP-ribosylation is a regulator of TNF-induced death
  13. The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL
  14. Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL
  15. Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis
  16. Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL
  17. Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosis
  18. A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells
  19. Location, location, location: A compartmentalized view of TNF-induced necroptotic signaling
  20. Necroptosis is dispensable for the development of inflammation-associated or sporadic colon cancer in mice
  21. A toolbox for imaging RIPK1, RIPK3 and MLKL in mouse and human cells
  22. MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis
  23. Identification of MLKL membrane translocation as a checkpoint in necroptotic cell death using Monobodies
  24. Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS
  25. VDAC2 enables BAX to mediate apoptosis and limit tumor development
  26. Endogenous fibrinolysis facilitates clot retraction in vivo
  27. Protein aggregation or liberation during cell necrosis
  28. Passenger mutations and aberrant gene expression in congenic tissue plasminogen activator-deficient mouse strains
  29. MouseMove: an open source program for semi-automated analysis of movement and cognitive testing in rodents
  30. Dendritic Cell-Mediated Phagocytosis but Not Immune Activation Is Enhanced by Plasmin
  31. Activated platelets rescue apoptotic cells via paracrine activation of EGFR and DNA-dependent protein kinase
  32. Oxidation of an Exposed Methionine Instigates the Aggregation of Glyceraldehyde-3-phosphate Dehydrogenase
  33. Tissue-type plasminogen activator is an extracellular mediator of Purkinje cell damage and altered gait
  34. Nucleocytoplasmic Coagulation: An Injury-Induced Aggregation Event that Disulfide Crosslinks Proteins and Facilitates Their Removal by Plasmin
  35. The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans
  36. Neovascularization Is Attenuated With Aldosterone Synthase Inhibition in Rats With Retinopathy
  37. Compartment- and context-specific changes in tissue-type plasminogen activator (tPA) activity following brain injury and pharmacological stimulation
  38. Thrombin-induced activation of astrocytes in mixed rat hippocampal cultures is inhibited by soluble thrombomodulin
  39. Novel Role of Platelets in Mediating Inflammatory Responses and Ventricular Rupture or Remodeling Following Myocardial Infarction
  40. A nonfibrin macromolecular cofactor for tPA-mediated plasmin generation following cellular injury
  41. Low molecular weight contaminants in commercial preparations of plasmin and t-PA activate neurons
  42. Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function
  43. Two conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factor
  44. Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo
  45. Tissue-Type Plasminogen Activator: A Multifaceted Modulator of Neurotransmission and Synaptic Plasticity
  46. Vampire Bat Salivary Plasminogen Activator (Desmoteplase): A Unique Fibrinolytic Enzyme That Does Not Promote Neurodegeneration